Volume 77, Issue 5, Pages (March 2010)

Slides:



Advertisements
Similar presentations
Volume 132, Issue 1, Pages (January 2007)
Advertisements

Volume 66, Issue 4, Pages (October 2004)
Volume 79, Issue 11, Pages (June 2011)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 86, Issue 4, Pages (October 2014)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 56, Issue 4, Pages (October 1999)
Volume 78, Issue 4, Pages (August 2010)
IFN-γ and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers  Kidney.
Volume 55, Issue 5, Pages (May 1999)
Adrian Schreiber, Friedrich C. Luft, Ralph Kettritz 
Volume 132, Issue 1, Pages (January 2007)
Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity  Sang E. Lee, Ji-Min.
Volume 69, Issue 8, Pages (April 2006)
Efficient TRAIL-R1/DR4-Mediated Apoptosis in Melanoma Cells by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)  Bahtier M. Kurbanov, Christoph.
Volume 71, Issue 10, Pages (May 2007)
Volume 68, Issue 4, Pages (October 2005)
Volume 80, Issue 11, Pages (December 2011)
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Cyclooxygenase-2-dependent phosphorylation of the pro-apoptotic protein Bad inhibits tonicity-induced apoptosis in renal medullary cells  Christoph Küper,
Volume 55, Issue 5, Pages (May 1999)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
EGFR Regulates the Expression of Keratinocyte-Derived Granulocyte/Macrophage Colony-Stimulating Factor In Vitro and In Vivo  Francesca Mascia, Christophe.
Anne K. Berfield, Dennis L. Andress, Christine K. Abrass 
Volume 72, Issue 4, Pages (August 2007)
Volume 87, Issue 2, Pages (February 2015)
Volume 75, Issue 11, Pages (June 2009)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Volume 70, Issue 12, Pages (December 2006)
Volume 62, Issue 3, Pages (September 2002)
Volume 59, Issue 1, Pages (January 2001)
IFN-γ and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers  Kidney.
Volume 74, Issue 5, Pages (September 2008)
Volume 84, Issue 2, Pages (August 2013)
Volume 63, Issue 2, Pages (February 2003)
Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor  P.Y. Chuang, Q. Yu, W. Fang, J. Uribarri, J.C.
Volume 80, Issue 12, Pages (December 2011)
Volume 82, Issue 7, Pages (October 2012)
Volume 70, Issue 7, Pages (October 2006)
Induction of Adipose Differentiation Related Protein and Neutral Lipid Droplet Accumulation in Keratinocytes by Skin Irritants  Emmanuela Corsini, PhD,
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
BMP-7 protects mesangial cells from injury by polymeric IgA
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 55, Issue 2, Pages (February 1999)
Volume 67, Issue 2, Pages (February 2005)
Volume 73, Issue 1, Pages (January 2008)
Volume 70, Issue 2, Pages (July 2006)
Volume 73, Issue 11, Pages (June 2008)
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Volume 79, Issue 4, Pages (February 2011)
17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
Volume 66, Issue 4, Pages (October 2004)
Volume 53, Issue 4, Pages (April 1998)
Volume 85, Issue 3, Pages (March 2014)
Volume 82, Issue 3, Pages (August 2012)
Volume 62, Issue 2, Pages (August 2002)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Functional CCR9 Expression Is Associated with Small Intestinal Metastasis  Anne Letsch, Ulrich Keilholz, Dirk Schadendorf, Geraldine Assfalg, Anne Marie.
Volume 85, Issue 1, Pages (January 2014)
Volume 62, Issue 4, Pages (October 2002)
Mechanisms of tubulointerstitial injury in IgA nephropathy
Volume 70, Issue 5, Pages (September 2006)
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
Volume 60, Issue 4, Pages (October 2001)
Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis 
Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells  Yuzhi Hong, Wuding Zhou, Ke Li,
Volume 58, Issue 6, Pages (December 2000)
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Volume 56, Issue 4, Pages (October 1999)
Presentation transcript:

Volume 77, Issue 5, Pages 417-427 (March 2010) Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes  Rosanna Coppo, Valentina Fonsato, Sabrina Balegno, Emanuela Ricotti, Elisa Loiacono, Roberta Camilla, Licia Peruzzi, Alessandro Amore, Benedetta Bussolati, Giovanni Camussi  Kidney International  Volume 77, Issue 5, Pages 417-427 (March 2010) DOI: 10.1038/ki.2009.473 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Effect of native polymeric IgA (pIgA) or desialylated and degalactosylated pIgA (deSial/deGal) on podocyte (glomerular epithelial cell, GEC) monolayers. After 24 h of incubation of mesangial cells (MCs) with various IgA preparations, IgA-containing supernatants were removed, MCs were washed with medium and cultured for an additional 12 h (in some experiments, for 24 h). The culture medium was then recovered and incubated for 1 h with GECs. This procedure avoided a direct contact between GECs and IgA. (a–f) Representative micrographs of nephrin expression detected by immunofluorescence in control GECs (a), or in GECs incubated with supernatants of MCs conditioned with IgA1 isolated from a healthy subject (b), or in GECs conditioned with pIgA and recovered after 12 h (c) or 24 h (e) after medium change, or with deSial/deGal pIgA recovered after 12 h (d) or 24 h (f) after medium change. Original magnification × 630. (g) Semiquantitative analysis of nephrin expression evaluated as relative fluorescence intensity after GEC incubation with vehicle alone (Ctr) or with supernatants of MCs challenged with IgA1 isolated from healthy subjects, or with pIgA or aberrantly glycosylated pIgA (deSial/deGal pIgA), for 12 or 24 h. Data are expressed as mean±s.d. of five different experiments. ANOVA (analysis of variance) with Newmann–Keuls multicomparison test was performed: *P<0.05 deSial/deGal pIgA 12 h versus pIgA 12 h; #P<0.05 deSial/deGal pIgA 24 h versus pIgA 24 h. (h) Western blot analysis for nephrin and β-actin expression on podocytes treated for 1 h with vehicle alone (Ctrl), or with supernatants of MCs conditioned with pIgA or deSial/deGal pIgA and recovered after 12 or 24 h. Kidney International 2010 77, 417-427DOI: (10.1038/ki.2009.473) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Effect of aberrantly glycosylated IgA1 isolated from sera of patients with IgA nephropathy (IgAN) on nephrin expression by glomerular epithelial cells (GECs). (a–f) Representative micrographs of nephrin expression detected by immunofluorescence in control GECs (a), or in GECs treated for 1 h with conditioned medium from mesangial cells (MCs) stimulated for 24 h with native polymeric IgA (pIgA) (b), degalactosylated pIgA (deSial/deGal pIgA) (c) or with aberrantly glycosylated IgA1 isolated from sera of three representative patients with IgAN (d–f). Original magnification × 630. (g) Semiquantitative analysis of nephrin expression evaluated as relative fluorescence intensity after podocyte stimulation with conditioned medium recovered from MCs treated with vehicle alone (Ctr), native pIgA (pIgA), deSial/deGal pIgA or with aberrantly glycosylated IgA1 isolated from sera of three representative IgAN patients (p1, p2, p3). Data are expressed as mean±s.d. of five different experiments. ANOVA (analysis of variance) with Newmann–Keuls multicomparison test was performed: *P<0.05 deSial/deGal pIgA and sera from IgAN patients versus control podocytes. (h) Densitometric analysis and representative western blot of nephrin protein levels in lysates of control podocytes (lane 1, Ctr) or in those treated with conditioned medium from MCs stimulated for 24 h with aberrantly glycosylated IgA1 isolated from sera of p1, p2, p3 IgAN patients (lanes 2, 3 and 4), or from sera of a healthy subject (lane 5), in those treated with conditioned medium from MCs stimulated with deSial/deGal pIgA (lane 6) and with native pIgA (lane 7). Data are expressed as mean±s.d. of three different experiments. ANOVA with Newmann–Keuls multicomparison test was performed: *P<0.05 sera from IgAN patients versus healthy controls or deSial/deGal pIgA versus control podocytes. Kidney International 2010 77, 417-427DOI: (10.1038/ki.2009.473) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Flow cytometric analysis of downmodulation of nephrin expression in glomerular epithelial cells (GECs). (a–f) Representative flow cytometric analysis of GECs (black histograms; white histograms represent isotypic controls) incubated for 1 h with medium alone (a), or with conditioned medium recovered from mesangial cells (MCs) treated with native polymeric IgA (pIgA) (b), degalactosylated pIgA (deSial/deGal pIgA) (c) or with aberrantly glycosylated IgA1 isolated from sera of three representative IgA nephropathy (IgAN) patients (d–f). (g) Semiquantitative analysis of nephrin expression detected as percentage mean fluorescence in control podocytes and in podocytes treated for 1 h with conditioned medium recovered from MCs treated with native pIgA, deSial/deGal pIgA or with aberrantly glycosylated IgA1 isolated from sera of three representative IgAN patients (p1, p2, p3). Data are expressed as mean±s.d. of seven different experiments. ANOVA (analysis of variance) with Newmann–Keuls multicomparison test was performed: *P<0.05 deSial/deGal pIgA and sera from IgAN patients versus control podocytes. Kidney International 2010 77, 417-427DOI: (10.1038/ki.2009.473) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Effect of native polymeric IgA (pIgA) or degalactosylated pIgA (deSial/deGal pIgA) on podocyte cytoskeleton distribution. (a–c) Representative micrographs of F-actin distribution of glomerular epithelial cell (GEC) monolayers after incubation with medium alone (a) or with conditioned medium recovered from mesangial cells (MCs) treated with native pIgA (b) or deSial/deGal pIgA (c). There was a clear effect of cytoskeleton reorganization, with loss in stress fibers and cell retraction. In cells incubated with the supernatants of MCs cultured with native pIgA, no effect was detectable, and F-actin staining was similar to that of unstimulated GECs. F-actin was stained with fluorescein isothiocyanate–phalloidin (original magnification × 630). (d) Semiquantitative analysis of F-actin expression detected as relative fluorescence intensity after podocyte stimulation with medium alone or with conditioned medium recovered from MCs treated with native pIgA or deSial/deGal pIgA. Data are expressed as mean±s.d. of five different experiments. ANOVA (analysis of variance) with Newmann–Keuls multicomparison test was performed: *P<0.05 deSial/deGal pIgA versus control podocytes. Kidney International 2010 77, 417-427DOI: (10.1038/ki.2009.473) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 5 Role of platelet-activating factor (PAF) in nephrin loss. (a, b) PAF synthesis (expressed as ng per 106 cells) by cultured glomerular epithelial cells (GECs) stimulated for 10, 20, 30 and 60 min with tumor necrosis factor-α (TNF-α) (10 ng/ml) (a) or stimulated for 30 min with different doses of TNF-α (b). Data are expressed as mean±s.d. of three different experiments. (c, d) Representative micrographs of nephrin expression in control GECs (c) and in GECs treated for 1 h with 10 ng/ml of synthetic PAF (d) that induced nephrin loss. (e, f) Representative micrographs of nephrin expression in PAF acetylhydrolase (PAF-AH) GECs (e) and in PAF-AH GECs stimulated for 1 h with 10 ng/ml of synthetic PAF (f) showing no loss of nephrin ((c–f) Original magnification × 630). (h) Semiquantitative analysis of nephrin expression detected as relative fluorescence intensity after podocyte (dark column) or PAF-AH GEC (white column) stimulation with medium alone or with 10 ng/ml of synthetic PAF for 1 h. (g) Flow cytometric analysis showing the expression of PAF receptor on GECs (dark area; white area represents the isotypic control). Data are expressed as mean±s.d. of three different experiments. Student's t-test was performed: *P<0.05 control podocytes treated with synthetic PAF versus control podocytes. Kidney International 2010 77, 417-427DOI: (10.1038/ki.2009.473) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 6 Abrogation of nephrin downregulation induced by degalactosylated polymeric IgA (deSial/deGal pIgA) and by sera from IgA nephropathy (IgAN) patients in glomerular epithelial cells (GECs) treated with platelet-activating factor (PAF) receptor antagonist or WEB2170, and in PAF acetylhydrolase (PAF-AH) GECs. (a, d, g, j, m) Representative micrographs showing nephrin expression in control GECs (a) or in GECs treated for 1 h with conditioned medium recovered from mesangial cells (MCs) stimulated for 24 h with deSial/deGal pIgA (d) or with aberrantly glycosylated IgA1 isolated from sera of three representative IgAN patients (g, j, m); (b, e, h, k, n) representative micrographs showing nephrin expression in GECs previously treated with PAF receptor antagonist WEB2170 and stimulated with vehicle (b) or treated for 1 h with conditioned medium recovered from MCs stimulated for 24 h with deSial/deGal pIgA (e) or treated with aberrantly glycosylated IgA1 isolated from sera from IgAN patients (h, k, n); (c, f, i, l, o) representative micrographs showing nephrin expression in control PAF-AH-transfected podocytes (c) or in PAF-AH-transfected podocytes treated for 1 h with conditioned medium recovered from MCs stimulated for 24 h with deSial/deGal pIgA (f) or with aberrantly glycosylated IgA1 isolated from sera of IgAN patients (i, l, o). Original magnification × 630. (p) Semiquantitative analysis of nephrin expression detected as relative fluorescence intensity in normal GECs, in GECs after treatment with PAF receptor antagonist WEB2170 and in PAF-AH-transfected podocytes treated for 1 h with conditioned medium recovered from MCs stimulated for 24 h with deSial/deGal pIgA or with aberrantly glycosylated IgA1 isolated from sera of three representative IgAN patients. Data are expressed as mean±s.d. of five different experiments. ANOVA (analysis of variance) with Newmann–Keuls multicomparison test was performed: *P<0.05 deSial/deGal pIgA and sera from IgAN patients versus control podocytes. Kidney International 2010 77, 417-427DOI: (10.1038/ki.2009.473) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 6 Abrogation of nephrin downregulation induced by degalactosylated polymeric IgA (deSial/deGal pIgA) and by sera from IgA nephropathy (IgAN) patients in glomerular epithelial cells (GECs) treated with platelet-activating factor (PAF) receptor antagonist or WEB2170, and in PAF acetylhydrolase (PAF-AH) GECs. (a, d, g, j, m) Representative micrographs showing nephrin expression in control GECs (a) or in GECs treated for 1 h with conditioned medium recovered from mesangial cells (MCs) stimulated for 24 h with deSial/deGal pIgA (d) or with aberrantly glycosylated IgA1 isolated from sera of three representative IgAN patients (g, j, m); (b, e, h, k, n) representative micrographs showing nephrin expression in GECs previously treated with PAF receptor antagonist WEB2170 and stimulated with vehicle (b) or treated for 1 h with conditioned medium recovered from MCs stimulated for 24 h with deSial/deGal pIgA (e) or treated with aberrantly glycosylated IgA1 isolated from sera from IgAN patients (h, k, n); (c, f, i, l, o) representative micrographs showing nephrin expression in control PAF-AH-transfected podocytes (c) or in PAF-AH-transfected podocytes treated for 1 h with conditioned medium recovered from MCs stimulated for 24 h with deSial/deGal pIgA (f) or with aberrantly glycosylated IgA1 isolated from sera of IgAN patients (i, l, o). Original magnification × 630. (p) Semiquantitative analysis of nephrin expression detected as relative fluorescence intensity in normal GECs, in GECs after treatment with PAF receptor antagonist WEB2170 and in PAF-AH-transfected podocytes treated for 1 h with conditioned medium recovered from MCs stimulated for 24 h with deSial/deGal pIgA or with aberrantly glycosylated IgA1 isolated from sera of three representative IgAN patients. Data are expressed as mean±s.d. of five different experiments. ANOVA (analysis of variance) with Newmann–Keuls multicomparison test was performed: *P<0.05 deSial/deGal pIgA and sera from IgAN patients versus control podocytes. Kidney International 2010 77, 417-427DOI: (10.1038/ki.2009.473) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 7 In vivo expression of PAF-R and nephrin. (a–c) Representative micrographs showing PAF-R expression (a) in a tissue section of a representative IgA nephropathy (IgAN) nonproteinuric patient and nephrin expression in a healthy subject (b) or in a tissue section of a representative IgAN proteinuric patient (c). (d) Semiquantitative analysis of nephrin expression detected as relative fluorescence intensity in healthy controls (n=10 healthy subjects), and in nonproteinuric (n=6) or proteinuric IgAN patients (n=7). (e) Semiquantitative analysis of PAF acetylhydrolase (PAF-AH) activity detected as μmol/min/ml in healthy controls (n=10 healthy subjects), and in nonproteinuric (n=6) or in proteinuric IgAN patients (n=7). Proteinuric patients were considered as those with urinary protein loss >0.3 g/day. Data are expressed as mean±s.d. of three different experiments. ANOVA (analysis of variance) with Newmann–Keuls multicomparison test was performed: *P<0.05 proteinuric IgAN patients versus healthy subjects; #P<0.05 proteinuric IgAN patients versus nonproteinuric IgAN patients. Kidney International 2010 77, 417-427DOI: (10.1038/ki.2009.473) Copyright © 2010 International Society of Nephrology Terms and Conditions